EcoDrugPlus

Phosphoribosylglycinamide Formyltransferase

Ensembl ID : ENSEBUG00000002082
Gene Symbol: GART
1 Cross references
210 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSEBUG00000009778
Gene Symbol: PLK1
1 Cross references
188 Possible Orthologues:

Poly (Adp-Ribose) Polymerase 2

Ensembl ID : ENSEBUG00000012647
Gene Symbol: PARP2
1 Cross references
186 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 3

Ensembl ID : ENSEBUG00000010916
Gene Symbol: PARP3
1 Cross references
200 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSEBUG00000005397
Gene Symbol: PORCN
1 Cross references
267 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily N Member 3

Ensembl ID : ENSEBUG00000009497
Gene Symbol: KCNN3
1 Cross references
446 Possible Orthologues:

Potassium Channel, Subfamily K, Member 9

Ensembl ID : ENSEBUG00000016087
Gene Symbol: KCNK9
1 Cross references
222 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 21

Ensembl ID : ENSEBUG00000015123
Gene Symbol: KCNJ21
1 Cross references
450 Possible Orthologues:

Potassium Large Conductance Calcium-Activated Channel, Subfamily M, Alpha Member 1a

Ensembl ID : ENSEBUG00000016358
Gene Symbol: KCNMA1A
1 Cross references
335 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSEBUG00000009538
Gene Symbol: PSENEN
1 Cross references
185 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSEBUG00000008532
Gene Symbol: PTGER4A
1 Cross references
334 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSEBUG00000000889
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).